Geode Capital Management, LLC Vera Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,153,325 shares of VERA stock, worth $34.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,153,325

Previous 1,004,665 14.8%

Holding current value

$34.5 Million

Previous $44.4 Million 9.86%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$38.64 - $49.75 $5.74 Million - $7.4 Million	148,660 Added 14.8%	1,153,325 $48.8 Million
Q3 2024 Nov 12, 2024	BUY	$34.09 - $46.71 $689,402 - $944,616	20,223 Added 2.05%	1,004,665 $44.4 Million
Q2 2024 Aug 09, 2024	BUY	$33.72 - $48.82 $780,044 - $1.13 Million	23,133 Added 2.41%	984,442 $35.6 Million
Q1 2024 May 13, 2024	BUY	$14.91 - $49.14 $2.66 Million - $8.78 Million	178,593 Added 22.82%	961,309 $41.5 Million
Q4 2023 Feb 13, 2024	BUY	$9.29 - $16.0 $410,144 - $706,384	44,149 Added 5.98%	782,716 $12 Million
Q3 2023 Nov 13, 2023	BUY	$13.71 - $19.64 $1.2 Million - $1.73 Million	87,875 Added 13.5%	738,567 $10.1 Million
Q2 2023 Aug 11, 2023	BUY	$6.11 - $17.83 $1.04 Million - $3.04 Million	170,647 Added 35.55%	650,692 $10.4 Million
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $1.21 Million - $4.08 Million	222,979 Added 86.74%	480,045 $3.73 Million
Q4 2022 Feb 13, 2023	BUY	$15.74 - $22.19 $271,766 - $383,132	17,266 Added 7.2%	257,066 $4.97 Million
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $467,263 - $785,579	35,212 Added 17.21%	239,800 $5.11 Million
Q2 2022 Aug 12, 2022	BUY	$12.82 - $23.4 $26,165 - $47,759	2,041 Added 1.01%	204,588 $2.78 Million
Q1 2022 May 13, 2022	BUY	$17.8 - $28.06 $1.44 Million - $2.27 Million	80,965 Added 66.59%	202,547 $4.76 Million
Q4 2021 Feb 11, 2022	BUY	$15.01 - $35.8 $750,109 - $1.79 Million	49,974 Added 69.79%	121,582 $3.25 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $30.6 $761,343 - $1.7 Million	55,532 Added 345.43%	71,608 $1.24 Million
Q2 2021 Aug 13, 2021	BUY	$11.5 - $19.97 $184,874 - $321,037	16,076 New	16,076 $213,000

Others Institutions Holding VERA

# of Institutions

193

Shares Held

63.9M

Call Options Held

68.1K

Put Options Held

88.6K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $809M
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Vera Therapeutics, Inc. Transaction History